This inventor holds 2 USPTO granted patents. Top assignees: Leland Stanford Junior University, University of California. Active years: 1998-2021.
Company Filing History:
1 out of 5,497 
1 out of 15,988 
Years Active: 1998-2021
Title: David Lee Van Vranken: Innovator in Therapeutic Chemistry
Introduction
David Lee Van Vranken is a notable inventor based in Irvine, CA (US). He has made significant contributions to the field of therapeutic chemistry, holding 2 patents that focus on innovative small molecules and ligands.
Latest Patents
One of his latest patents is titled "Spiroindolinones and therapeutic uses thereof." This patent describes small molecules comprised of spiroindolinone analogues, which are designed to treat diseases such as fungal infections. The invention includes a stereoselective method of synthesis for creating these spiroindolinones, along with formulations and medicaments for various modes of administration.
Another significant patent is "Asymmetric ligands useful for transition metal catalyzed bond forming." This patent provides ligands that facilitate transition metal catalyzed bond forming reactions. The ligands are designed to enable flexible strategies for constructing five-membered carbocyclic rings with high enantioselectivity, showcasing the innovative approaches Van Vranken employs in his work.
Career Highlights
David Lee Van Vranken has worked at prestigious institutions, including the University of California and Leland Stanford Junior University. His work in these environments has allowed him to develop and refine his innovative ideas in therapeutic chemistry.
Collaborations
Throughout his career, Van Vranken has collaborated with notable coworkers, including Shelley Ren-An Lane and Ilandari Dewage Udara Anulal Premachandra. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
David Lee Van Vranken is a distinguished inventor whose work in therapeutic chemistry has led to valuable innovations. His patents reflect a commitment to addressing medical challenges through creative solutions.